Outcomes17

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

1 to 17 of 17

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Total Ocular Surface Disease Index	Day 29		score on a scale	MEAN
SECONDARY	Lissamine Green Staining	Day 29		score on a scale	MEAN
SECONDARY	Tear Film Break-up Time	Day 29		seconds	MEAN
SECONDARY	Conjunctival Redness	Day 29		score on a scale	MEAN
SECONDARY	Schirmer's Test	Day 29		mm	MEAN
SECONDARY	Cochet-Bonnet Corneal Sensitivity Test	Day 29		cm	MEAN
SECONDARY	Tear Osmolarity	Day 29		mOsm/L	MEAN
SECONDARY	Matrix Metalloprotienase-9 (MMP-9) is a Marker of Inflammation.	Day 29		Participants	COUNT_OF_PARTICIPANTS
SECONDARY	Ocular Discomfort (Scale 1)	Day 29		score on a scale	MEAN
SECONDARY	Ocular Discomfort (Scale 2)	Day 29		score on a scale	MEAN
SECONDARY	Visual Analog Scale for Pain	Day 29		score on a scale	MEAN
SECONDARY	Fluorescein Staining	Day 29		score on a scale	MEAN
SECONDARY	Visual Acuity Measured by Assessing Average Change in LogMAR Units for Both Eyes at Day 29. LogMAR Units Range From 0-1.0, With the Higher the Number Indicating a Worsening in Vision.	Day 29	Mean change in visual acuity for both eyes measured by LogMAR units (0-1.0)	units on a scale	MEAN
OTHER_PRE_SPECIFIED	Number of Participants With Treatment-related Adverse Events	Adverse events will be collected from first dose of study drug to 30 days after treatment discontinuation (Day 29 + 4 weeks).		Participants	COUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIED	Slit-lamp Biomicroscopy	Day 29		participants	NUMBER
OTHER_PRE_SPECIFIED	Intraocular Pressure	Day 29		mmHg	MEAN
OTHER_PRE_SPECIFIED	Dilated Fundoscopy	Day 29		participants	NUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03660475/outcomes